CTD // Fund

BGI Co-win

Private equity and asset management firm focused on biotech, biopharma and med-tech companies

BGI Co-win

china

BGI Co-win is an institutional investor (Growth Equity) founded in 2016 and headquartered in Shenzhen, China. Private equity and asset management firm focused on biotech, biopharma and med-tech companies. As an institutional investor, the firm manages capital on behalf of institutional limited partners, deploying capital across selected investment opportunities with strong growth potential.

Stage: Private Equity, Private Equity
HQ: Shenzhen, china
Founded: 2016
Website: https://www.bgi-cowin.com
LinkedIn: https://linkedin.com/company/%E5%8D%8E%E5%A4%A7%E5%85%B1%E8%B5%A2bgi-cowin

Institutional InvestorHealthcareHealthTechBiotechBiopharma

Related startups

Speediance

Speediance is a smart home gym equipment company that develops all-in-one AI-powered fitness machines enabling users to practice strength training,…

HealthTech · Shenzhen, China

Sleepace

Sleepace provides sleep tracking devices with companion mobile applications, offering products such as the Reston sleep monitoring device that tracks sleep…

HealthTech · Shenzhen, China

Galixir

Galixir is a biotechnology company that develops AI-based molecular drug discovery tools.

HealthTech · Beijing, China

📊 Revenue multiples by stage & sector — free comps-based startup valuation calculator.

⚠️ Common pitch mistakes we see →

Preparing to pitch BGI Co-win?

CrackTheDeck analyzes your pitch deck before the meeting — structure, narrative, investor fit.

Analyze My Deck →